CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT01839981 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Acinar Cell Adenocarcinoma of the Pancreas
Duct Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions

DRUG: 6,8-bis(benzylthio)octanoic acid

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]